{"id":"https://openalex.org/W2018046489","doi":"https://doi.org/10.1097/00008390-199606000-00009","title":"Low-dose integrated chemoimmunohormonotherapy with cisplatin, subcutaneous interleukin-2, interferon and tamoxifen for advanced metastatic melanoma???a pilot study","display_name":"Low-dose integrated chemoimmunohormonotherapy with cisplatin, subcutaneous interleukin-2, interferon and tamoxifen for advanced metastatic melanoma???a pilot study","publication_year":1996,"publication_date":"1996-06-01","ids":{"openalex":"https://openalex.org/W2018046489","doi":"https://doi.org/10.1097/00008390-199606000-00009","mag":"2018046489","pmid":"https://pubmed.ncbi.nlm.nih.gov/8819129"},"language":"en","primary_location":{"id":"doi:10.1097/00008390-199606000-00009","doi":"https://doi.org/10.1097/00008390-199606000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-199606000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005794650","display_name":"M.G. Bernengo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M G Bernengo","raw_affiliation_strings":["Clinica Dermatologica dell'Universit\u00e0 di Torino, Italy","Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell'Universit\u00e0 di Torino, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109320432","display_name":"Doveil Gc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G C Doveil","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109389259","display_name":"Maria Tiziana Bertero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Bertero","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066790760","display_name":"Pietro Quaglino","orcid":"https://orcid.org/0000-0003-4185-9586","observed_orcids":["https://orcid.org/0000-0003-4185-9586"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Quaglino","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110633738","display_name":"M. T. Fierro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M T Fierro","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037046430","display_name":"Paola Savoia","orcid":"https://orcid.org/0000-0002-1636-8411","observed_orcids":["https://orcid.org/0000-0002-1636-8411"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Savoia","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081888023","display_name":"Antonella Appino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A Appino","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"last","author":{"id":null,"display_name":"S Colonna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Colonna","raw_affiliation_strings":["Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Dermatologica dell' Universit\u00e0 di Torino, Via Cherasco 23, 10126 Torino, Italy. Fax: ( + 39) 11 674 034","institution_ids":["https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I55143463"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.14148472,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"6","issue":"3","first_page":"257","last_page":"265"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/subcutaneous-interleukin-2","display_name":"subcutaneous interleukin-2","score":0.8899999856948853},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7540000081062317},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":1.0},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/low-dose-il-2","display_name":"low-dose interleukin-2","score":0.8230000138282776},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.574999988079071},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.6290000081062317},{"id":"https://openalex.org/keywords/hla-dr","display_name":"HLA-DR","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.5220000147819519},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7956134080886841},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.7085740566253662},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5789629220962524},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5448349714279175},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.48571711778640747},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4679960608482361},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.4351993203163147},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4278087019920349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4129980206489563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3359692692756653},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2252461314201355},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.148340106010437},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13372820615768433},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.04973435401916504}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/00008390-199606000-00009","doi":"https://doi.org/10.1097/00008390-199606000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-199606000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:8819129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8819129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Clinical Trial"},{"id":"pmh:oai:iris.unito.it:2318/42161","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/42161","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2127123639","https://openalex.org/W1958294026","https://openalex.org/W1988339002","https://openalex.org/W2427424949","https://openalex.org/W2064578370","https://openalex.org/W2004138031","https://openalex.org/W2527388725","https://openalex.org/W2177186844","https://openalex.org/W108229836","https://openalex.org/W1993530200"],"abstract_inverted_index":{"Recently,":[0],"Khayat":[1],"et":[2],"al.":[3],"reported":[4],"that":[5,37,168],"high-dose":[6],"recombinant":[7],"interleukin-2":[8],"(rIL-2)":[9],"i.v.":[10],"may":[11,40,183],"induce":[12],"tumour":[13],"regressions":[14],"in":[15,58,141,158],"metastatic":[16,63],"melanoma":[17,64],"patients":[18,65,82,160],"through":[19,43],"an":[20,133],"association":[21],"with":[22,68,181,188],"cisplatin":[23],"(CDDP)":[24],"and":[25,72,91,121,127,144,153,178],"alpha-interferon":[26],"(alpha-IFN).":[27],"Treatment-related":[28],"toxicities":[29],"are,":[30],"however,":[31],"important.":[32],"Previous":[33],"studies":[34],"have":[35,184],"demonstrated":[36],"rIL-2":[38,56],"toxicity":[39],"be":[41],"reduced":[42],"a":[44,59],"subcutaneous":[45,55,172],"injection.":[46],"In":[47],"order":[48],"to":[49,190],"evaluate":[50],"the":[51],"effectiveness":[52],"of":[53,147,171],"low":[54,126],"doses":[57,170],"chemoimmuno-hormonotherapeutic":[60],"combination,":[61],"36":[62],"were":[66],"treated":[67],"CDDP,":[69],"rIL-2,":[70,173],"alpha-IFN":[71],"tamoxifen":[73],"(TAM).":[74],"The":[75,112],"overall":[76,105],"response":[77,85,89,97],"rate":[78],"was":[79,99,107,115,125,156],"47.2%:":[80],"five":[81],"had":[83],"complete":[84],"(14%),":[86],"12":[87],"partial":[88],"(33%)":[90],"13":[92],"stable":[93],"disease":[94],"(36%).":[95],"Median":[96,104],"duration":[98],"6.4":[100],"months":[101,109],"(range:":[102,110],"2-29+).":[103],"survival":[106],"10":[108],"3-36+).":[111],"CDDP/rIL-2/alpha-IFN/TAM":[113],"regimen":[114],"effective":[116],"both":[117,142],"on":[118],"soft":[119],"tissue":[120],"visceral":[122],"metastases.":[123],"Toxicity":[124],"patient":[128],"management":[129],"did":[130],"not":[131],"require":[132],"intensive":[134],"care":[135],"unit.":[136],"A":[137],"statistically":[138],"significant":[139],"increase":[140],"percentage":[143],"absolute":[145],"values":[146],"lymphocytes,":[148],"eosinophils,":[149],"CD3+/CD4+,":[150],"CD25+,":[151],"CD16/56+":[152],"HLA-DR+":[154],"cells":[155],"found":[157],"all":[159],"after":[161],"two":[162],"treatment":[163],"courses.":[164],"This":[165],"study":[166],"shows":[167],"lower":[169,194],"as":[174,176],"well":[175],"CDDP":[177],"alpha-IFN,":[179],"associated":[180],"TAM,":[182],"similar":[185],"anticancer":[186],"efficacy":[187],"respect":[189],"Khayat's":[191],"schedule":[192],"but":[193],"toxicity.":[195]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}